Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pharmaceutical Product Development Inc (PPDI) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pharmaceutical Product Development Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1003124.
Total stock buying since 2010: $0.
Total stock sales since 2010: $8,256,678.
Total stock option exercises since 2010: $5,692,755.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2011 | 0 | $0 | 216,061 | $6,254,644 | 224,342 | $4,555,225 |
| 2010 | 0 | $0 | 78,479 | $2,002,034 | 51,753 | $1,137,530 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2011-05 | 0 | $0 | 118,835 | $3,582,838 | 118,835 | $2,410,194 |
| 2011-03 | 0 | $0 | 16,562 | $457,524 | 16,562 | $253,066 |
| 2011-02 | 0 | $0 | 80,664 | $2,214,282 | 88,945 | $1,891,965 |
| 2010-11 | 0 | $0 | 51,753 | $1,330,677 | 51,753 | $1,137,530 |
| 2010-08 | 0 | $0 | 26,726 | $671,357 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-05-27 | Colvin Paul (EVP--Clinical Development) | Sale | 5,659 | 28.70 | 162,413 |
| 2011-05-27 | Colvin Paul (EVP--Clinical Development) | Option Ex | 5,659 | 20.20 | 114,283 |
| 2011-05-26 | Colvin Paul (EVP--Clinical Development) | Sale | 100 | 28.70 | 2,870 |
| 2011-05-26 | Colvin Paul (EVP--Clinical Development) | Option Ex | 100 | 19.94 | 1,994 |
| 2011-05-20 | Colvin Paul (EVP--Clinical Development) | Sale | 600 | 29.01 | 17,406 |
| 2011-05-20 | Colvin Paul (EVP--Clinical Development) | Option Ex | 600 | 20.20 | 12,117 |
| 2011-05-03 | Hartman Judd (General Counsel) | Sale | 112,476 | 30.23 | 3,400,149 |
| 2011-05-03 | Hartman Judd (General Counsel) | Option Ex | 112,476 | 20.29 | 2,281,800 |
| 2011-03-01 | Magnuson Terry (Director) | Sale | 8,281 | 27.70 | 229,383 |
| 2011-03-01 | Magnuson Terry (Director) | Option Ex | 8,281 | 15.28 | 126,533 |
| 2011-03-01 | Frank Fred (Director) | Sale | 8,281 | 27.55 | 228,141 |
| 2011-03-01 | Frank Fred (Director) | Option Ex | 8,281 | 15.28 | 126,533 |
| 2011-02-28 | Wilkinson Michael O. (Chief Information Officer) | Sale | 21,667 | 28.19 | 610,792 |
| 2011-02-28 | Wilkinson Michael O. (Chief Information Officer) | Option Ex | 21,667 | 23.09 | 500,399 |
| 2011-02-28 | Grange David L (Chief Executive Officer) | Sale | 34,501 | 26.00 | 897,026 |
| 2011-02-28 | Grange David L (Chief Executive Officer) | Option Ex | 34,501 | 20.45 | 705,545 |
| 2011-02-24 | Mcneill John A Jr (Director) | Option Ex | 8,281 | 15.28 | 126,533 |
| 2011-02-14 | Wilkinson Michael O. (Chief Information Officer) | Sale | 24,496 | 28.84 | 706,464 |
| 2011-02-14 | Wilkinson Michael O. (Chief Information Officer) | Option Ex | 24,496 | 22.84 | 559,488 |
| 2010-11-03 | Grange David L (Chief Executive Officer) | Sale | 51,380 | 25.71 | 1,320,979 |
| 2010-11-03 | Grange David L (Chief Executive Officer) | Option Ex | 51,380 | 21.98 | 1,129,332 |
| 2010-11-02 | Grange David L (Chief Executive Officer) | Sale | 373 | 26.00 | 9,698 |
| 2010-11-02 | Grange David L (Chief Executive Officer) | Option Ex | 373 | 21.98 | 8,198 |
| 2010-08-09 | Mario Ernest (Director) | Sale | 26,726 | 25.12 | 671,357 |
Insider trading activities including stock purchases, stock sales, and option exercises of PPDI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pharmaceutical Product Development Inc (symbol PPDI, CIK number 1003124) see the Securities and Exchange Commission (SEC) website.